Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer
Clinical trial NCT04834349 · WITHDRAWN
Trial details
- NCT number
- NCT04834349
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-09
- Primary completion
- 2022-11-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.